Old West Investment Management’s Kindred Biosciences, Inc. KIN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-45,682
Closed -$227K 59
2016
Q3
$227K Sell
45,682
-746
-2% -$3.15K 0.17% 49
2016
Q2
$164K Buy
46,428
+16,907
+57% +$62.2K 0.12% 56
2016
Q1
$101K Sell
29,521
-1,967
-6% -$6.95K 0.08% 60
2015
Q4
$107K Sell
31,488
-9,361
-23% -$43.4K 0.1% 66
2015
Q3
$212K Sell
40,849
-1,379
-3% -$8.5K 0.16% 67
2015
Q2
$287K Sell
42,228
-1,788
-4% -$12.7K 0.2% 66
2015
Q1
$314K Sell
44,016
-210
-0.5% -$1.45K 0.21% 73
2014
Q4
$329K Buy
+44,226
New +$375K 0.2% 75

Other funds holding KIN

Old West Investment Management's KIN Position: Q4 2016 in Review

Old West Investment Management sold out of Kindred Biosciences, Inc. (KIN) in Q4 2016, closing a stake of 45,682 shares — an estimated $227K sold.

Old West Investment Management first reported a position in KIN in Q4 2014 and held it in 8 quarters. The position peaked at $329K in Q4 2014. 43 funds tracked by Wall St. Rank hold KIN as of Q4 2016.

  • Old West Investment Management reported no remaining Kindred Biosciences, Inc. position as of Q4 2016 after selling out during the quarter.
  • Old West Investment Management sold 45,682 Kindred Biosciences, Inc. shares in Q4 2016, an estimated $227K.
  • Old West Investment Management first reported a position in Kindred Biosciences, Inc. in Q4 2014 and held it in 8 quarters.
  • Old West Investment Management's Kindred Biosciences, Inc. position peaked at $329K in Q4 2014.
  • 43 funds tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q4 2016.

Based on Old West Investment Management's 13F filing for Q4 2016, filed 13 Feb 2017.